Lincomycin and clindamycin: their role in chemotherapy of anaerobic and microaerophilic infections.
D000190:Actinomyces / Q000187:drug effects; D000196:Actinomycosis / Q000188:drug therapy; D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D001431:Bacteriological Techniques; D001439:Bacteroides / Q000187:drug effects; D001442:Bacteroides Infections / Q000188:drug therapy; D002245:Carbon Dioxide / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D002981:Clindamycin / Q000494:pharmacology / Q000627:therapeutic use*; D003013:Clostridium / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008034:Lincomycin / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D008431:Maternal-Fetal Exchange; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D012293:Rifampin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D010406:Penicillins; D002245:Carbon Dioxide; D002981:Clindamycin; D004917:Erythromycin; D002701:Chloramphenicol; D008034:Lincomycin; D013752:Tetracycline; D012293:Rifampin